Fig. 1.
Survival rates of C57BL/6 mice injected with Toxoplasma gondii, Lewis lung carcinoma (LLC) cells or Quil-A. Mice were checked daily for eight weeks following cancer cell injection, to measure survival rates. The groups (n=10 per group) were as follows: LLC, injected in the femoral muscle with 1×105 viable LLC cells; TG, infected with five cysts of the Me49 strain of T. gondii; TG/LLC, received both Toxoplasma parasites and LLC cells; QA, received 20 µg/mouse of Quil-A twice weekly for 3 weeks; LLC/QA, received both LLC cells and Quil-A; TG/QA, received both T. gondii and Quil-A; TG/LLC/QA, received T. gondii, LLC cells, and Quil-A.